Major GLP-1 trials including SUSTAIN and STEP studies reported hypoglycemia rates of 28% in Type 2 diabetes patients on semaglutide monotherapy, compared to 2040% in those on insulin
Despite these numbers, GLP-1 drugs account for relatively small shares of total Medicaid spending and prescriptions, the report noted about 0.5% of all Medicaid prescriptions and 3.7% of gross Medicaid spending
In the world of federal regulatory enforcement, ignoring FDA warning letters is roughly equivalent to ignoring a tornado warning while standing in an open field
This piece digs into how those three pieces fit together, the exact cancellation math, and what's worth double-checking before you enroll
So, they decided to come up with a product that would ensure skin safety while whitening your skin
You give your body glutathione in a form that it can actually use